🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
11.97
-0.74 (-5.82%)
Nov 20, 2026, 3:04 PM CST

SHE:300406 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
1,3611,3431,6481,7371,5081,598
Other Revenue
12.9612.9611.284.42.881
1,3741,3561,6591,7421,5111,599
Revenue Growth
-4.14%-18.29%-4.75%15.27%-5.53%88.58%
Cost of Revenue
278.85284.5361.88445.01384.12448.5
Gross Profit
1,0951,0711,2971,2971,1271,151
Selling, General & Admin
369.44408.88457.67491.04457.36444.38
Research & Development
175.95181.73188.53162.9137.2127.01
Other Operating Expenses
24.1317.8815.4514.9712.8512.92
Operating Expenses
605.35634.85665.03692.35625.46602.71
Operating Income
489.72436.16632.01604.27501.29548.17
Interest Expense
-50.93-49.44-47.61-46.99-52.64-21.59
Interest & Investment Income
33.5322.5719.8225.9521.4815.74
Currency Exchange Gain (Loss)
-1.45-1.45-0.1-0.122.21-0.29
Other Non Operating Income (Expenses)
1.59-0.462.39-3.5-28.33-19.94
EBT Excluding Unusual Items
472.46407.38606.52579.62444.01522.09
Impairment of Goodwill
-174.77-174.77---3.03-
Gain (Loss) on Sale of Investments
1.04-----
Gain (Loss) on Sale of Assets
-1.79-2.87-2.11-3.5-2.680.16
Asset Writedown
-2.24-2.24-1.38-0.21-2.29-0.11
Other Unusual Items
19.188.7617.6617.6413.3514.85
Pretax Income
313.88236.25620.69593.55449.35536.99
Income Tax Expense
62.245.7183.8771.4854.8967.33
Earnings From Continuing Operations
251.68190.54536.82522.07394.46469.66
Minority Interest in Earnings
-1.04-0.661.471.67-5.37-64.01
Net Income
250.64189.87538.29523.74389.1405.65
Net Income to Common
250.64189.87538.29523.74389.1405.65
Net Income Growth
-42.70%-64.73%2.78%34.60%-4.08%261.30%
Shares Outstanding (Basic)
588593579582581588
Shares Outstanding (Diluted)
588593598595614588
Shares Change
-1.71%-0.79%0.49%-3.00%4.37%7.25%
EPS (Basic)
0.430.320.930.900.670.69
EPS (Diluted)
0.430.320.900.880.670.69
EPS Growth
-41.70%-64.44%2.27%31.47%-2.99%236.88%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
543.35525.87546.36437.06299.69275.9
Free Cash Flow Per Share
0.930.890.910.730.490.47
Dividend Per Share
0.3500.7000.4000.2000.1000.100
Dividend Growth
-61.11%75.00%100.00%100.00%0%0.66%
Gross Margin
79.70%79.01%78.19%74.45%74.58%71.96%
Operating Margin
35.64%32.18%38.10%34.70%33.18%34.27%
Profit Margin
18.24%14.01%32.45%30.07%25.75%25.36%
Free Cash Flow Margin
39.55%38.80%32.93%25.09%19.84%17.25%
EBITDA
556.47504.06701.44658.03554.35590.51
EBITDA Margin
40.50%37.19%42.28%37.78%36.69%36.92%
D&A For EBITDA
66.7567.969.4253.7653.0542.33
EBIT
489.72436.16632.01604.27501.29548.17
EBIT Margin
35.64%32.18%38.10%34.70%33.18%34.27%
Effective Tax Rate
19.82%19.35%13.51%12.04%12.22%12.54%
Revenue as Reported
1,3741,3561,6591,742-1,599
Advertising Expenses
-138.12153.01194.01200.07186.98